HLB Life ScienceHLB생명과학
067630 · KOSDAQ · ₩067630 · HLB생명과학
₩3,340▼ ₩15 (0.45%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Investor relations (IR) event기업설명회(IR)개최Oct 12, 2026Open on DART
Predicted impact: Low· Actual: −11.6% vs sector, volume 0.5× normal (5 trading days)
- Acquisition of Bonds Prior to Maturity After Issuance of Convertible Bonds (Including Overseas Convertible Bonds) (13th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)Aug 31, 2026Open on DART
- Acquisition of shares in another company타법인주식및출자증권취득결정Aug 28, 2026Open on DART
- Sale of shares in another company타법인주식및출자증권처분결정Aug 26, 2026Open on DART
- Adjustment of Exchange Price (16th Series)교환가액의조정 (제16회차)Aug 20, 2026Open on DART
- Acquisition of Bonds Prior to Maturity After Issuance of Convertible Bonds (Including Overseas Convertible Bonds) (13th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)Aug 14, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 1, 2026Open on DART
- Acquisition of Bonds Prior to Maturity After Issuance of Convertible Bonds (Including Overseas Convertible Bonds) (13th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)Jun 18, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure) (17th Convertible Bond Issue)증권발행결과(자율공시) (제17회차 CB)Jun 8, 2026Open on DART
- Acquisition of Bonds Prior to Maturity After Issuance of Convertible Bonds (Including Overseas Convertible Bonds) (13th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)May 29, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)May 28, 2026Open on DART
- Adjustment of Exchange Price (16th Series)교환가액의조정 (제16회차)May 21, 2026Open on DART
- Trading halt주권매매거래정지 (중요한 영업정지)May 15, 2026Open on DART
- Major Matters Report (Business Suspension)주요사항보고서(영업정지)May 15, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Change of CEO대표이사변경Mar 31, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Mar 26, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Mar 26, 2026Open on DART
- Audit report submitted감사보고서제출Mar 23, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 23, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Acquisition of Bonds Prior to Maturity After Issuance of Convertible Bonds (Including Overseas Convertible Bonds) (13th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)Mar 3, 2026Open on DART
- Acquisition of Bonds Prior to Maturity After Issuance of Convertible Bonds (Including Overseas Convertible Bonds) (13th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)Feb 25, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure) (16th Exchangeable Bonds)증권발행결과(자율공시) (제16회차 EB)Feb 20, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 20, 2026Open on DART
- Acquisition of Bonds Prior to Maturity After Issuance of Convertible Bonds (Including Overseas Convertible Bonds) (13th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)Feb 19, 2026Open on DART
- Sale of shares in another company타법인주식및출자증권처분결정Feb 12, 2026Open on DART
- Exchangeable bond issue decision주요사항보고서(교환사채권발행결정)Jan 22, 2026Open on DART
- Change of CEO대표이사변경Dec 31, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
- Major Matters Report (Business Suspension)주요사항보고서(영업정지)Nov 27, 2025Open on DART
- Securities Issuance Results (Voluntary Disclosure) – 15th Series Exchangeable Bonds (EB)증권발행결과(자율공시) (제15회차 EB)Nov 14, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Exchangeable bond issue decision주요사항보고서(교환사채권발행결정)Nov 3, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 13, 2025Open on DART
- Merger decision기타주요경영사항 (회사 합병결정 철회)Aug 1, 2025Open on DART
- Amended: Merger decision[기재정정]주요사항보고서(회사합병결정)Aug 1, 2025Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과Jul 10, 2025Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Jun 19, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Jun 19, 2025Open on DART
- Adjustment of Conversion Price (13th Series)전환가액의조정 (제13회차)May 29, 2025Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의May 19, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: HLB Life Science / HLB생명과학 / 067630 / KRX:067630
Source: KRX statistical information